Most Read Articles
5 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 5 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 3 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

DASH diet improves bone health in postmenopausal women

13 Jun 2020

The Dietary Approaches to Stop Hypertension (DASH) is associated with better bone outcomes than the Alternative Health Eating Index (AHEI-2010) or the Mediterranean Diet Score (MeDS) in postmenopausal women not taking oestrogen, but all dietary quality indices promote bone health, according to a study.

“Methodological differences across scores suggest that a bone-specific index that builds on existing indices and that can be used to address dietary differences across cultural and ethnic minority populations should be considered,” the investigators said.

Participants (mean age, 59.9 years; 71 percent female) from the Boston Puerto Rican Osteoporosis Study with complete bone and dietary data were included. Indices were calculated from validated food frequency data. Dual X-ray absorptiometry was used to measure bone mineral density (BMD).

The investigators assessed the associations between dietary indices (z-scores) and their individual components with BMD and osteoporosis using ANCOVA and logistic regression, respectively. At the lumbar spine and femoral neck, stratified by male, pre- and postmenopausal women.

All dietary indices correlated with a reduced risk of osteoporosis (odds ratio, 0.54–0.75), but DASH (score, 11–38) showed better results, being associated with higher trochanter (0.026±0.006 g/cm2; p<0.001), femoral neck (0.022±0.006 g/cm2; p<0.001), total hip (0.029±0.006 g/cm2; p<0.001), and lumbar spine BMD (0.025±0.007 g/cm2; p=0.001) among postmenopausal women not on oestrogen.

AHEI (score, 25–86) also correlated with spine and all hip sites (p<0.02), while MeDS (0–9) was associated only with total hip (p=0.01) and trochanter BMD (p=0.007) in postmenopausal women.

On the other hand, results for men or premenopausal women did not reach statistical significance.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 5 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 3 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.